Loading organizations...
Loading organizations...
Biotechnology company revolutionizing antibody-based drug discovery.
RubrYc Therapeutics has raised $17.5M across 2 funding rounds.
RubrYc Therapeutics has raised $17.5M in total across 2 funding rounds.
RubrYc Therapeutics has raised $17.5M in total across 2 funding rounds.
RubrYc Therapeutics's investors include Tom Isett, Hayan Health Networks, Paladin Capital Group, Third Point Ventures, Vital Venture Capital.
RubrYc Therapeutics has raised $17.5M across 2 funding rounds. Most recently, it raised $7.5M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 25, 2021 | $7.5M Series A | Tom Isett | Hayan Health Networks, Paladin Capital Group, Third Point Ventures, Vital Venture Capital |
| Apr 11, 2018 | $10.0M Series A | Third Point Ventures | Paladin Capital Group, Vital Venture Capital |